Nikolaj Torp

1.1k total citations · 2 hit papers
25 papers, 412 citations indexed

About

Nikolaj Torp is a scholar working on Epidemiology, Pathology and Forensic Medicine and Hepatology. According to data from OpenAlex, Nikolaj Torp has authored 25 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 12 papers in Pathology and Forensic Medicine and 12 papers in Hepatology. Recurrent topics in Nikolaj Torp's work include Liver Disease Diagnosis and Treatment (24 papers), Alcohol Consumption and Health Effects (12 papers) and Liver Disease and Transplantation (11 papers). Nikolaj Torp is often cited by papers focused on Liver Disease Diagnosis and Treatment (24 papers), Alcohol Consumption and Health Effects (12 papers) and Liver Disease and Transplantation (11 papers). Nikolaj Torp collaborates with scholars based in Denmark, Spain and United Kingdom. Nikolaj Torp's co-authors include Mads Israelsen, Aleksander Krag, Maja Thiele, Stine Johansen, Camilla Dalby Hansen, Katrine Prier Lindvig, Katrine Holtz Thorhauge, Peter Andersen, Johanne Kragh Hansen and Sönke Detlefsen and has published in prestigious journals such as Journal of Hepatology, Nature Reviews Gastroenterology & Hepatology and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Nikolaj Torp

19 papers receiving 408 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease

2023 116 citations Maria Kjærgaard, Katrine Prier Lindvig et al. Journal of Hepatology profile →
Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study

2024 75 citations Mads Israelsen, Nikolaj Torp et al. The Lancet. Gastroenterology & hepatology profile →

Peers

Nikolaj Torp

EPIDE

PFM

HEPAT

EDM

Stine Johansen Denmark

Nadège Barri‐Ova France

Katrine Holtz Thorhauge Denmark

Johanne Kragh Hansen Denmark

Romy Ouziel Belgium

Heejoon Jang South Korea

J. Marrero United States

Elisabeth P.C. Plompen Netherlands

Micheline Njiké‐Nakseu France

Hans-Jörg Cordes Germany

Stine Johansen Denmark

Nikolaj Torp

357 ×1.0

EPIDE

166 ×1.0

PFM

201 ×1.2

HEPAT

121 ×0.9

EDM

34 ×0.8

Citations per year, relative to Nikolaj Torp Nikolaj Torp (= 1×) peers Stine Johansen

Countries citing papers authored by Nikolaj Torp

Since Specialization

Citations

This map shows the geographic impact of Nikolaj Torp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolaj Torp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolaj Torp more than expected).

Fields of papers citing papers by Nikolaj Torp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikolaj Torp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolaj Torp. The network helps show where Nikolaj Torp may publish in the future.

Co-authorship network of co-authors of Nikolaj Torp

This figure shows the co-authorship network connecting the top 25 collaborators of Nikolaj Torp. A scholar is included among the top collaborators of Nikolaj Torp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikolaj Torp. Nikolaj Torp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hansen, Camilla Dalby, Lorenz Balcar, K. Bech, et al.. (2025). PNPLA3 and TM6SF2 exacerbate the impact of alcohol and metabolic dysfunction on liver fibrosis. JHEP Reports. 8(1). 101649–101649.

Balcar, Lorenz, Marta Tonon, Nikolaj Torp, et al.. (2025). Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation. Alimentary Pharmacology & Therapeutics. 62(11-12). 1202–1211.

Torp, Nikolaj, Louise China, Mads Israelsen, et al.. (2025). Targeted albumin infusions in hospitalized patients with cirrhosis receiving terlipressin: A post-hoc analysis of ATTIRE. Annals of Hepatology. 30(2). 101941–101941. 1 indexed citations

Krag, Aleksander, Nikolaj Torp, Zobair M. Younossi, & Mads Israelsen. (2025). Reporting discrepancy of alcohol intake affecting estimated prevalence of MetALD and ALD. The Lancet. Gastroenterology & hepatology. 10(4). 282–284. 9 indexed citations

Torp, Nikolaj, Mads Israelsen, Maja Thiele, Mary E. Rinella, & Aleksander Krag. (2025). Phosphatidylethanol in steatotic liver disease. Journal of Hepatology. 83(5). 1189–1203. 3 indexed citations

Israelsen, Mads, Katrine Holtz Thorhauge, Peter Andersen, et al.. (2025). Steatotic Liver Disease Classification Is Dynamic, Affecting Clinical Trial Eligibility and Subclass-Specific Treatments. Clinical Gastroenterology and Hepatology. 23(13). 2509–2518. 6 indexed citations

Torp, Nikolaj, K. Bech, Stine Johansen, et al.. (2025). Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study. The Lancet. Gastroenterology & hepatology. 10(11). 975–985. 1 indexed citations

Torp, Nikolaj, Mads Israelsen, Minneke J. Coenraad, et al.. (2024). Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial. BMJ Open. 14(2). e079309–e079309. 6 indexed citations

Thorhauge, Katrine Holtz, Georg Semmler, Stine Johansen, et al.. (2024). Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease. Journal of Hepatology. 81(1). 23–32. 20 indexed citations

10.

Torp, Nikolaj, Mads Israelsen, & Aleksander Krag. (2024). The steatotic liver disease burden paradox: unravelling the key role of alcohol. Nature Reviews Gastroenterology & Hepatology. 22(4). 281–292. 13 indexed citations

11.

Lindvig, Katrine Prier, Sören Möller, Katrine Holtz Thorhauge, et al.. (2024). FRI-045 Superior prognostic accuracy of the LiverPRO score versus FIB-4 in predicting liver-related events in a cohort of 457, 152 individuals. Journal of Hepatology. 80. S205–S206. 1 indexed citations

12.

Israelsen, Mads, Nikolaj Torp, Stine Johansen, et al.. (2024). Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study. The Lancet. Gastroenterology & hepatology. 9(3). 218–228. 75 indexed citations breakdown →

13.

Torp, Nikolaj, Stine Johansen, Johanne Kragh Hansen, et al.. (2024). Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake. JHEP Reports. 7(1). 101200–101200. 11 indexed citations

14.

Stankevič, Evelina, Mads Israelsen, Helene Bæk Juel, et al.. (2023). Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation‐related markers. Liver International. 43(12). 2680–2691. 15 indexed citations

15.

Johansen, Stine, Mads Israelsen, Ida Falk Villesen, et al.. (2023). Validation of scores of PRO‐C3 to predict liver‐related events in alcohol‐related liver disease. Liver International. 43(7). 1486–1496. 8 indexed citations

16.

Kjærgaard, Maria, Katrine Prier Lindvig, Katrine Holtz Thorhauge, et al.. (2023). Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 Individuals. Clinical Gastroenterology and Hepatology. 22(5). 1037–1047.e9. 28 indexed citations

17.

Kjærgaard, Maria, Katrine Prier Lindvig, Katrine Holtz Thorhauge, et al.. (2023). Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease. Journal of Hepatology. 79(2). 277–286. 116 indexed citations breakdown →

18.

Torp, Nikolaj, Mads Israelsen, Mette Juul Nielsen, et al.. (2021). Binge drinking induces an acute burst of markers of hepatic fibrogenesis (PRO‐C3). Liver International. 42(1). 92–101. 15 indexed citations

19.

Torp, Nikolaj, Mads Israelsen, Bjørn Stæhr Madsen, et al.. (2021). Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis. JHEP Reports. 3(3). 100287–100287. 4 indexed citations

20.

Israelsen, Mads, Min Kim, Tommi Suvitaival, et al.. (2021). Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication. JHEP Reports. 3(5). 100325–100325. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact